D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
PUT
EOG Resources
EOG
$74.4B
| $9.59M | 0.01% |
102,900
+9,200
| +10% | +$856K |
|
1127
Halozyme
HALO
$9.9B
| $9.51M | 0.01% |
553,386
+233,400
| +73% | +$3.77M |
|
1128
Arthur J. Gallagher & Co
AJG
$68.2B
| $9.51M | 0.01% |
108,512
+75,327
| +227% | +$6.29M |
|
1129
CALL
Norfolk Southern
NSC
$76.1B
| $9.49M | 0.01% |
47,600
+26,200
| +122% | +$5.2M |
|
1130
Tactile Systems Technology
TCMD
$626M
| $9.45M | 0.01% |
165,941
-88,038
| -35% | -$4.59M |
|
|
DISCK
1131
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $9.44M | 0.01% |
+331,888
| New | +$9.01M |
|
|
B
1132
Barrick Mining
B
$61.5B
| $9.43M | 0.01% |
598,037
+101,097
| +20% | +$1.34M |
|
1133
PUT
Verizon
VZ
$201B
| $9.43M | 0.01% |
165,000
-281,600
| -63% | -$16.2M |
|
|
AKRX
1134
DELISTED
Akorn Inc
AKRX
| $9.42M | 0.01% |
1,828,657
+63,897
| +4% | +$246K |
|
|
GCP
1135
DELISTED
GCP Applied Technologies Inc.
GCP
| $9.41M | 0.01% |
415,655
-90,561
| -18% | -$2.44M |
|
1136
CALL
Essex Property Trust
ESS
$18.9B
| $9.4M | 0.01% |
32,200
+10,000
| +45% | +$2.88M |
|
|
HES
1137
DELISTED
Hess
HES
| $9.39M | 0.01% |
147,755
+132,235
| +852% | +$8.18M |
|
1138
Silicon Laboratories
SLAB
$7.17B
| $9.38M | 0.01% |
90,717
+19,351
| +27% | +$1.87M |
|
|
GTS
1139
DELISTED
Triple-S Management Corporation
GTS
| $9.38M | 0.01% |
413,251
+12,028
| +3% | +$273K |
|
1140
Tyson Foods
TSN
$21.5B
| $9.35M | 0.01% |
115,816
+16,161
| +16% | +$1.24M |
|
1141
PUT
Stellantis
STLA
$16.7B
| $9.33M | 0.01% |
675,000
+100,000
| +17% | +$1.45M |
|
|
FLG
1142
Flagstar Bank National Association
FLG
$5.83B
| $9.33M | 0.01% |
+311,479
| New | +$10.1M |
|
1143
Calix
CALX
$2.34B
| $9.31M | 0.01% |
1,419,090
+234,719
| +20% | +$1.58M |
|
1144
CALL
Sarepta Therapeutics
SRPT
$1.63B
| $9.28M | 0.01% |
61,100
-20,000
| -25% | -$2.43M |
|
1145
Hilltop Holdings
HTH
$2.28B
| $9.26M | 0.01% |
435,538
-65,900
| -13% | -$1.33M |
|
|
CSII
1146
DELISTED
Cardiovascular Systems, Inc.
CSII
| $9.26M | 0.01% |
215,810
-177,803
| -45% | -$6.9M |
|
1147
CALL
Factset
FDS
$10.1B
| $9.26M | 0.01% |
32,300
+14,000
| +77% | +$3.87M |
|
1148
First Horizon
FHN
$12.3B
| $9.25M | 0.01% |
+619,276
| New | +$8.96M |
|
|
BLUE
1149
PUT
DELISTED
bluebird bio
BLUE
| $9.22M | 0.01% |
5,597
+1,737
| +45% | +$3M |
|
1150
PUT
Illumina
ILMN
$29.2B
| $9.2M | 0.01% |
25,700
+7,093
| +38% | +$2.24M |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.